JFIFPhotoshop 3.08BIMd@Small Trial Finds GLP-1 Lowers Heavy Drinking Days in Individual720260501PSCIENMAGUAuthorgSmall Trial Finds GLP-1 Lowers Heavy Drinking Days in Individuals with Alcohol Use Disorder and Obesity Science@https://scienmag.com/small-trial-finds-glp-1-lowers-heavy-drinki© 2026 Sciencehttps://scienmag.com/In a groundbreaking clinical trial, investigators have demonstrated that once-weekly semaglutide injections can dramatically reduce heavy drinking days among adults battling obesity and alcohol use disorder. This pioneering research, published in the distinguished journal The Lancet, documents a compelling therapeutic effect of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), in modifying alcohol consumption behavior […]ScienceMedMedicineMedicine%behavioral modification with GLP-1 RA'clinical trials on alcohol use disorder#comorbid obesity and AUD management0GLP-1 receptor agonists for alcohol use disorder#neural reward circuits in addiction)novel treatments for alcohol use disorder,obesity and alcohol consumption intervention"once-weekly semaglutide injections,pharmacotherapy for heavy drinking reduction+randomized controlled trial in AUD patients%semaglutide effects on alcohol intake(semaglutide treatment in obesity and AUDC    !'"#%%%),($+!$%$C   $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$"A!1"AQaq2#3Rb$45BCSr.!1AQ"23q#BRa ?G8sZJSnǶm,'>TsO8Iu%DSL{ϡW,W\yhwY ϵzi?f`ٚ-4 iGDi H&{?Lm $Gṍ?{n%)$%X>ա^=7wr3 <ΟVO $5l*+[\{{6=*[޳9ldJ T:U91AڙS13֞5;l5PBxQuɥ]@RA T-`[_zfCyy8y'ʥk,4[WU u)1ڇh@Z)iOj!HPbk1'*'tBq]VHf9[:ڱd}?T‚ ވ1uO9W9 6ٗUϗX$6Bwֵ4]᫣ז;/},mi:?5r&e3"-aXy[TYl~.Rxw(͇O5#1V74r8嫔NOiW&yE* qN  6O,ڥuR&T%]wQ]zmsnoڅA4f-ij9OJ Y,1sHR(}8Vwγ7I *ÇRUیKKZ ILTܒj) UF|N< /JČZ Q?L*r'}7RTr:LFpCa;Va1gm ZW oNkv?Zťf-FdV_֤JAU!8mT]YZ" (H} 4p=ϥfZӴ;tpuQ-(<)9B QLF5ֳE) }> tZ+qߕ#*s-:,'! JЮJ½ÎY6v>8zjAoįg[-I1r"t~)AޕRؙ-Lf ҔtVKqmնZPg#lVʏ OL%*yi\ Nۡ\ d Zt&xx pSS>_S|-J=7zǕNe I=ץ4qzvqf HsYJw,:Ҵd7w E2]a6w8w7jtpepeCC##3Sv954koGdo2'j|z"8G pA4"TԜXsRؘUP7#sn"AQKAɋ+ʥ4QR_d@|h2SiC𬍼 qե \<)5bnDfb<)2ZwӌnE2.3t훀Ge/gjƝDut[-G ;'JȲDI'´d7J@'> ~Y-ML/Jd2j;F՟:#% Bxi@<ĞlZ=*Wj=̤%H>bTK32ˑoۢW1:unoQ-[m{RēЌPC. -v}%g`vnu!⡀4[tJSAmAwGL J(`j-wӲ"C%LRjmaIZqYg sZ۵)pX| nMq+XV )x#%ˍt)uMYk=Ava?5җӰfgI#AAjզƍvCYwjJoMj+jxy,Cnd|jxi[[E%f=)?i‘jcJԖFMUQwyU[߼)fDoϞ3R8ԯ`Od n RfLfsXc>HqH#zHb29Jʵn \LlwN\ϒcCg=jTVg$_!4.0uVC,+5U!o׏&sMJ]asBs֋dKinsT!=./Ԡ3w(%#"[u*>&0y00%mv)ߋ!!-'֕xԉIBxƆ8RZ5(D ƖTAnyk-ʖKծT$T|׮eGk-N!oZ\5s=mAR^u˩)1UIܾ&L"҂! YP;a Σx'>d,+˯+*Ƙ-WXxҒ^⻨w}0wPOU6zQsrnB:$:4dH(WLx4j۩3RfN\*9t|󡬲RjW{v h[3jyAe [aԵb.oUJ?ֱ$T؟}0ikdTDRNN[iSm7%}\iF(m׭zJ*N1E~pu:m%w8̭FnŦ5d/NNzLH+Ei\SJk̆fq%.KrҮ 8Pr@^*qBV Ov^(pw'X[*dt?qG)))4).ְ'}\ Qx]r(:Ӎu} 27DR Kv;6Z.Ofro[[.GYRN1õV:H9fV?Ja!^;whS# CoHd?ZVx<. 'P%v\Jx9kn5UM]@w49RL4!LRҏiWR.4Gm-%dn8W1~v]n;m*)@$+{֍=EL˯-+N3V7kЂ>4BLK 4ƗMp*@ʾ+_>lIwvKTu;WG*-n4B-@*+M=LZ*ࢱPdn\ϐH+֛?sLh9c>>g-<-ZÄAesfv+pU x1;Q.wp :R˂|JGz}LΟRsGJJU5 .H .Oz [gs'lYGqkͷIR ٓ&ۥn1-zl B TگQc:␂26kG) )Ab*aB2 /◎Uښ0$DYW)N'4sRSE=eQv8E~õK9sI. U6?'9,@A>x>5*LlIH򤴗q;yyDe"5P-ހMS\K/2FxN>eɕ-_YWUN8m*J?Q>W%zPNVtv˗ղbe lHZnrTҘ~2!TJZ.5n8$9e!GT=8ž$/oZ_Ǟte)79RW`Z\hCJG6}M g񨍇`#JY. ;^gh2>}ZHvtQ*VGr"9P׮gLo 8Fsj@OQd%TF`z+ ԩ/-Hj;JRz>\V,!KA’Ѻ]MoS.GCVIFHSG0AJ(Fb-\pwCm[>؈3U 1$F8:HZyl9q7, l)njs<}]3"vJ\qE$ֹ LW"c"t:Cʿ?2̼|iOH?*Y-) %^taruH*%' 8RNb凴ꐗm7}f¸ +DRcj=> a5^+RӧmV ` P0kBڳ;E`%Ad)'caS Vޭ5T/Lv{'; *;[/$ު_ws/;>Bm>u*ؑ?G_y֥JÞnUKTT_Zh@|q+YSZlP|RtM擸p*V'1PTTD=T^監-O;j:OtԩLbMG- ;q'jTz4sQd﹩Rp5*TOO